Revelation Biosciences Inc.
13F holders, Q2 2024 (June 30)7holders
2new positions
2sold out
$1.90avg. 13F price*
At the end of Q2 2024, 7 institutions reported holding Revelation Biosciences Inc. in their 13F filings, unchanged from Q1 2024. 2 opened new positions and 2 sold out. The largest holders were UBS Group AG ($52K), HRT Financial LP ($32K) and Tower Research Capital LLC (TRC) ($10K).
- Company
- Revelation Biosciences Inc.
- CUSIP
- 76135L507
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $32K |
| Exits | 2 | $830 |
All 13F filers, Q1 2024 → Q2 2024: 43,069 shares bought and 303 shares sold, net +42,766 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| UBS Group AG | 0.00% | Add +553.3% | 27,328 | $52K |
| HRT Financial LP | 0.00% | New | 16,943 | $32K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +60.5% | 5,006 | $10K |
| Royal Bank of Canada | 0.00% | Add +3000.0% | 1,116 | $2K |
| Bank of America Corp. | 0.00% | New | 13 | $25 |
| Morgan Stanley | 0.00% | No change | 5 | $10 |
| POM Investment Strategies, LLC | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is REVELATION BIOSCIENCES INC's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.